Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
MT-ND4 pseudogene 30 (MTND4P30) is a nuclear DNA pseudogene related to the mitochondrial NADH dehydrogenase 4 (MT-ND4) gene[6][7]. Pseudogenes such as MTND4P30 are fragments or copies of mitochondrial genes found in the nuclear genome; they do not produce functional mitochondrial complex I subunits and do not possess known biological or therapeutic roles. While functional MT-ND4 is essential in mitochondrial electron transport and linked to some diseases, the MTND4P30 pseudogene is not transcribed into a functional protein and is not involved in mitochondrial respiration, disease pathogenesis, or drug targeting[7]. MT-ND4 pseudogene 30 (MTND4P30) is a nuclear, non-coding pseudogene—not a functional receptor, enzyme, or disease-associated protein[6][7].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on MT-ND4 pseudogene 30 (MTND4P30).